Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis.

Autor: E P; San Giovanni di Dio Hospital, Florence, Italy., M S; Department of Biomedical Sciences and Human Oncology, University 'Aldo Moro' of Bari.. Electronic address: marta.simone@uniba.it., E P; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., A B; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., L P; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., M N; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy., L R; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., R F; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., L T; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., M F; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., A G; MS Centre, Hospital of Gallarate, Italy., L P; MS Centre, Hospital of Gallarate, Italy., Mg M; MS Centre, Binaghi Hospital, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy., E C; MS Centre, Binaghi Hospital, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy., G F; MS Centre, Binaghi Hospital, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Italy., F P; Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Italy., C C; Department G.F. Ingrassia, Section of Neurosciences, University of Catania, Italy., M F; IRCCS Hospital San Raffaele, Milan, Italy., L M; IRCCS Hospital San Raffaele, Milan, Italy., E M; IRCCS Hospital San Raffaele, Milan, Italy., Rg V; Department of Basic Medical Sciences, Neuroscience and Sense Organs. University ' Aldo Moro' of Bari, Italy., L M; Department of Biomedical Sciences and Human Oncology, University 'Aldo Moro' of Bari., B G; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy., Mp A; Department NEUROFARBA, Section Neurosciences, University of Florence, Italy; IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
Jazyk: angličtina
Zdroj: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2020 Jul; Vol. 42, pp. 102145. Date of Electronic Publication: 2020 May 04.
DOI: 10.1016/j.msard.2020.102145
Abstrakt: Background: There is limited information on socio-professional attainment in pediatric-onset multiple sclerosis (POMS) compared with adult-onset MS (AOMS).
Objectives: To assess socio-professional outcomes in POMS and AOMS and variables influencing these outcomes.
Methods: One-hundred-fifteen AOMS and 111 POMS patients underwent neuropsychological testing (Brief Repeatable Battery, Stroop test), assessment of cognitive reserve (CR) (education, National Adult reading Test -NART, Barratt Simplified Measure of Social Status), fatigue (Fatigue Severity Scale), depression (Montgomery-Åsberg Depression Rating Scale), socio-professional performance (Work and Social Adjustment Scale -WSAS). Prognostic factors were assessed using logistic and linear multivariable regression analyses.
Results: 34.5% of patients showed CI without significant differences between AOMS and POMS. Cognitively impaired patients were older (p=0.024), had higher EDSS scores (p=0.041) and lower IQ (p<0.001) compared with cognitively preserved patients. Better WSAS scores were associated with younger age (p=0.007), lower EDSS (p<0.001) and higher educational levels (p=0.001). Fourteen POMS (13%) and six AOMS (5%) achieved a lower educational level compared with their parents (p=0.06). POMS exhibiting a lower than expected educational level, had a lower median IQ compared with the remaining subjects (101 vs 106.5; p=0.03). Unemployment rate was predicted by higher disability (p=0.044) and lower educational levels (p<0.001). Occupational complexity was positively correlated to educational level (<0.001) and NART scores (<0.040).
Conclusion: This study underscores the complex relationships between cognition and educational, socioeconomic and professional attainment in MS and supports a protective role of CR in both POMS and AOMS.
Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Simone M., Falautano M., Minacapelli E., Pippolo L., Viterbo R., Goretti B., Prestipino E., Niccolai C., Bellinvia A., Fonderico M, Tudisco L., Fratangelo R., Margari L., have nothing to disclose; Amato M.P., received research grants and honoraria as a speaker and member of advisory boards by Bayer, Biogen, Merck, Novartis, Sanofi Genzyme, Teva, Celgene and Roche; Patti F. reports personal fees from Almirall, personal fees from Bayer, grants and personal fees from Biogen, personal fees from Celgene, grants and personal fees from Merck, personal fees from Roche, personal fees from Sanofi, personal fees from Novartis, personal fees from TEVA, grants from Reload onlus, grants from FISM, grants from MIUR, outside the submitted work; Portaccio E. served on a scientific advisory board for Biogen and Merck Serono. He received honoraria from Biogen, Merck Serono, Teva, Genzyme . Chisari CG has received grants for congress participation from Almirall, Biogen, Merck Serono, Novartis, Roche, Sanofi Genzyme, and TEVA; Moiola L. received honoraria for speaking at scientific conferences and for participating to advisory board from Biogen-Idec, Serono, Sanofi, Novartis, TEVA, Roche; Ghezzi A. received honoraria for speaking and consultancy from Merck-Serono, Novartis, Biogen-Idec, Genzyme; Razzolini L. received research, editorial grants and honoraria as a speaker and member of advisory boards by:Bayer, Biogen, Merck, Novartis, Sanofi Genzyme, Teva, Almirall, Roche; Pastò L. received research, editorial grants and honoraria as a speaker and member of advisory boards by:Bayer, Biogen, Merck, Novartis, Sanofi Genzyme, Teva, Almirall, Roche; Cocco E. and Marrosu M. have received honoraria for consultancy or speaking from Bayer, Biogen, Novartis, Sanofi, Genzyme, Serono and Teva; Fenu G. received honoraria for consultancy from Novartis, Biogen and for speaking from Merck Serono and Teva.
(Copyright © 2020 Elsevier B.V. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: